Sign inJoin waitlistJoin the waitlist

MC

Mark Cornfeld

Medical Oncology

Credentials: ·

Research

Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease
Journal of Clinical Oncology · 2010 · 189 citations
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic…
European Journal of Cancer · 2012 · 167 citations
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Cancer Chemotherapy and Pharmacology · 2015 · Last of 13 authors · 137 citations

Paul Engstrom
3 papers
GH
Gary Hudes
2 papers
MF
Marwan Fakih
2 papers
Peter O'Dwyer
2 papers · 1 as a fellow
Peter Voorhees
2 papers
AD
Adi Diab
1 paper
Al Benson
1 paper
AP
Alison Portnoy
1 paper
AP
Amita Patnaik
1 paper
AT
Anthony Tolcher
1 paper
Carl Allen
1 paper
Carlos Rodriguez-Galindo
1 paper